Xenin
From Wikipedia, the free encyclopedia
This article includes a list of references or external links, but its sources remain unclear because it lacks in-text citations. You can improve this article by introducing more precise citations. |
Xenin is a peptide hormone produced by a subpopulation of chromogranin A-positive endocrine cells in the mucous membrane of the duodenum. The peptide has been found in man, dog, pig, rat, and rabbit.
In humans, xenin circulates in the blood plasma[1]. There is a relationship between peaks of xenin concentration in the plasma and the third phase of the Migrating Motor Complex. For example, infusion of synthetic xenin in fasting volunteers will cause phase III activity. After a meal (the 'postprandial state'), infusion of xenin increases both contraction frequency and the percentage of aborally propagated contractions. In higher concentrations xenin stimulates exocrine pancreatic secretion and inhibits the gastrin-stimulated secretion of acid in dogs. Xenin is also produced in neuroendocrine tumors of the duodenal mucosa.
In vitro, xenin interacts with the neurotensin receptor 1.
Contents |
[edit] Structure and sequence
Xenin is a 25-amino acid polypeptide. The amino acid sequence of xenin is identical to the N-terminal end of cytoplasmic coatomer subunit alpha[2], from which xenin can be cleaved by aspartic proteases. Xenin is structurally related to the amphibian peptide xenopsin and to the neuropeptide neurotensin.
[edit] Proxenin
Proxenin is the precursor to xenin. It is a 35-amino acid polypeptide. Like xenin, its amino acid sequence exactly matches the N-terminus of coatomer subunit alpha[2].
[edit] References
- ^ Feurle GE, Hamscher G, Kusiek R, Meyer HE, Metzger JW.J. Biol. Chem.1992;267:22305-22309
- ^ a b UniProtKB/Swiss-Prot entry P53621 COPA_HUMAN
- Feurle GE, Neurogastroenterol. Mot.2003;13:237-246
- Feurle GE, Anlauf M, Hamscher G, Arnold R, Klöppel G, Weihe B. Gastroenterology 2002;123:1616-1626
- Feurle GE, Ikonomu S,Partoulas G, Stochus B, Hamscher G. Regulatory peptides 2003;111:153-159